Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results
Portfolio Pulse from
Krystal Biotech reported a significant increase in revenues for the fourth quarter of 2024, with a 116% rise to $91.1 million compared to the same period in 2023.
February 19, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Krystal Biotech's fourth quarter 2024 revenues increased by 116% to $91.1 million compared to the fourth quarter of 2023, indicating strong financial performance.
The significant increase in revenues suggests strong business performance and potential for future growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100